Loading…

Significance of chemotherapy-free interval and tumor regression grade in patients with recurrent esophageal squamous cell carcinoma receiving chemotherapy with fluorouracil and platinum after esophagectomy following preoperative chemotherapy

Background In Japan, standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC) includes preoperative chemotherapy with fluorouracil plus cisplatin followed by esophagectomy. However, its efficacy is unclear in patients with recurrent disease with 

Saved in:
Bibliographic Details
Published in:Esophagus : official journal of the Japan Esophageal Society 2022-04, Vol.19 (2), p.240-249
Main Authors: Okunaka, Mashiro, Kotani, Daisuke, Demachi, Ken, Fujiwara, Hisashi, Sakashita, Shingo, Yoshino, Takayuki, Fujita, Takeo, Kojima, Takashi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background In Japan, standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC) includes preoperative chemotherapy with fluorouracil plus cisplatin followed by esophagectomy. However, its efficacy is unclear in patients with recurrent disease with 
ISSN:1612-9059
1612-9067
DOI:10.1007/s10388-021-00885-3